Ftse Mib
34.860,16
0,01%
DAX
20.405,92
-0,11%
S&P 500
6.050,24
-0,02%
NASDAQ
19.925,68
0,11%
Bitcoin
101.495,79
1,43%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Alvontech (ALVO) Alvontech (ALVO) Notizie

Alvontech

ALVO
11,81
0,15 (1,29%)
Ultimo aggiornamento: 20:44:54
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/11/202422:05GLOBEAlvotech Reports Financial Results for the First Nine Months..
07/11/202414:00GLOBEAlvotech Attending Citi's Global Healthcare Conference on..
04/11/202413:00GLOBEEuropean Medicines Agency Confirms Acceptance of Marketing..
30/10/202413:30GLOBEAlvotech to Report Financial Results for the First Nine..
25/10/202414:00GLOBEAlvotech Meeting Investors and Presenting at the Jefferies..
22/10/202413:00GLOBEAlvotech and Teva Announce U.S. FDA Approval of Additional..
10/10/202411:00GLOBEEuropean Medicines Agency Confirms Acceptance of Marketing..
25/9/202411:00GLOBEAlvotech Initiates Confirmatory Patient Study for AVT16, a..
26/8/202415:14GLOBEAlvotech to Participate in the Morgan Stanley 22nd Annual..
16/8/202411:57IHMARKETNEWSH&R Block Shares Surge 10% on Profit and Dividend Boost,..
15/8/202422:15GLOBEAlvotech Reports Record Revenues and Adjusted EBITDA for the..
15/8/202412:09IHMARKETNEWSU.S. Futures Rise on Easing Inflation, Oil Prices Rise
15/8/202410:30GLOBEEuropean Medicines Agency Confirms Acceptance of Marketing..
01/8/202422:02GLOBEAlvotech to Report Financial Results for the First Half of..
22/7/202412:30GLOBESTADA and Alvotech launch Uzpruvo, the first approved..
11/7/202410:45GLOBEAlvotech Announces Closing of Private Debt Financing
02/7/202415:00GLOBEAlvotech Announces Positive Topline Results from..
01/7/202423:35GLOBEAlvotech Issues New Shares to Holders of Convertible Bonds
01/7/202411:10GLOBEAlvotech Announces Record Preliminary Results for Revenues..
26/6/202410:50GLOBEAlvotech Receives Conversion Notices for Majority of..
18/6/202410:01GLOBEAlvotech and Advanz Pharma Sign Commercialization Agreement..
11/6/202410:00GLOBEAlvotech and STADA add to strategic alliance through..
07/6/202410:00GLOBEAlvotech Announces Strategic Refinancing Agreement
29/5/202414:05GLOBEAlvotech to Participate in Jefferies Healthcare Conference..
21/5/202423:15GLOBEAlvotech Reports Financial Results for First Quarter of 2024..
21/5/202416:05BWAlvotech and Dr. Reddy’s Enter Into Collaboration for..
21/5/202414:00GLOBEAlvotech and Dr. Reddy’s enter into collaboration for..
21/5/202413:13IHMARKETNEWSU.S. Index Futures Open Lower Amid Nasdaq Record, Fed..
21/5/202402:25BWTeva and Alvotech Announce SIMLANDI® (adalimumab-ryvk)..
13/5/202414:00GLOBEAlvotech Announces Webcast of First Quarter 2024 Financial..
02/5/202413:15GLOBEAlvotech Announces Participation at BofA Securities..
30/4/202410:00BWU.S. Commercialization Agreement with Quallent to Drive..
24/4/202410:00GLOBEAlvotech Announces Topline Results from a Confirmatory..
19/4/202412:10GLOBEAlvotech signs U.S. agreement to expand access for newly..
16/4/202423:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/4/202423:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
03/4/202413:41GLOBEAlvotech Hosts Audio Call for Investors at 8:15 am EDT on..
22/3/202421:15GLOBEAlvotech Announces Increase in Number of Own Shares
20/3/202421:15GLOBEAlvotech Reports Financial Results for Full Year 2023 and..
20/3/202412:17IHMARKETNEWSU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s..
05/3/202422:00GLOBEAlvotech Announces Webcast of Full Year 2023 Financial..
29/2/202422:05GLOBEAlvotech Appoints Interim Chief Quality Officer
26/2/202410:25GLOBEAlvotech Accepts Offer for the Sale of Shares for a value of..
24/2/202402:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
24/2/202402:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
15/2/202412:30GLOBEAlvotech Announces Expected Global Market Entry Dates for..
29/1/202410:00GLOBEAlvotech Announces Positive Top-Line Results from a..
19/1/202418:31DJNAlvotech Shares Climb After FDA Concludes Facility..
19/1/202417:30GLOBEAlvotech Provides Update on Status of Biologics License..
10/1/202409:30GLOBESTADA and Alvotech secure approval for Uzpruvo, Europe’s..
Apertura: 11,91 Min: 11,70 Max: 12,09
Chiusura: 11,66

La tua Cronologia

NASDAQ
ALVO
Alvontech
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network